Elsevier

The Annals of Thoracic Surgery

Volume 60, Issue 5, November 1995, Pages 1169-1176
The Annals of Thoracic Surgery

Thoracic surgery directors association award
Disparate effects of nitric oxide on lung ischemia-reperfusion injury

https://doi.org/10.1016/0003-4975(95)00697-JGet rights and content

Background.

Inhaled nitric oxide (•NO) has been found to be a potent pulmonary vasodilator. We assessed whether •NO, through this function or others, could alleviate lung reperfusion injury.

Methods.

Rats underwent thoracotomy, with clamps used to create left lung ischemia. After 90 minutes of ischemia, clamps were released, permitting reperfusion for either 30 minutes or 4 hours. Additional animals received inhaled •NO via the ventilator to determine its effects on reperfusion injury.

Results.

Lung injury, measured by increased vascular permeability using iodine-125—labeled bovine serum albumin leakage, was significantly increased in ischemic-reperfused animals compared with time-matched shams not undergoing ischemia. Inhaled •NO delivered at the start of reperfusion worsened injury at 30 minutes but was protective at 4 hours. The increased injury could be avoided either by delaying •NO for 10 minutes or by treating the animals with superoxide dismutase before reperfusion. •NO reversed postischemic pulmonary hypoperfusion at 4 hours, as measured by labeled microspheres. Lung neutrophil content was significantly reduced at 4 hours in •NO-treated animals.

Conclusions.

•NO is toxic early in reperfusion, due to its interaction with superoxide, but is protective at 4 hours of reperfusion, due to reversal of postischemic lung hypoperfusion and reduction of lung neutrophil sequestration.

References (28)

  • YamashitaC et al.

    Effect of prostaglandin I2 and superoxide dismutase of reperfusion injury of warm ischemic lung

    Ann Thorac Surg

    (1992)
  • PhamS et al.

    Interleukin-6, a marker of preservation injury in clinical lung transplantation

    J Heart Lung Transplant

    (1992)
  • PalmerRMJ et al.

    Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

    Nature

    (1987)
  • IgnarroLJ et al.

    Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

    Proc Natl Acad Sci USA

    (1987)
  • Cited by (0)

    Presented at the Thirty-first Annual Meeting of The Society of Thoracic Surgeons, Palm Springs, CA, Jan 30–Feb 1, 1995.

    View full text